Both in Pharmaceuticals
Immix Biopharma vs Design Therapeutics
Over the past year IMMX returned +102.1% and DSGN returned +59.4%; their daily moves had a correlation of 0.32.
IMMX +102.1% DSGN +59.4%Growth of $1, one year, split-adjusted
| Metric | IMMX | DSGN |
|---|---|---|
| Price | $7.68 | $10.68 |
| Market cap | $636.7M | $668.4M |
| Today | −3.76% | −3.44% |
| 1 month | −24.9% | −12.7% |
| 6 months | −17.4% | −19.7% |
| Year to date | +46.8% | +13.9% |
| 1 year | +106.5% | +64.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $232.1M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | 54.7% |
| Short % of float | 22.5% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).